A detailed history of One Wealth Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, One Wealth Advisors, LLC holds 18,972 shares of BMY stock, worth $1.09 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
18,972
Previous 6,182 206.89%
Holding current value
$1.09 Million
Previous $256,000 283.2%
% of portfolio
0.15%
Previous 0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$39.66 - $51.75 $507,251 - $661,882
12,790 Added 206.89%
18,972 $981,000
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $111,693 - $147,047
-2,775 Reduced 30.98%
6,182 $256,000
Q1 2024

Apr 15, 2024

BUY
$47.98 - $54.4 $429,756 - $487,260
8,957 New
8,957 $485,000
Q3 2023

Nov 01, 2023

SELL
$57.89 - $64.73 $109,180 - $122,080
-1,886 Reduced 22.31%
6,567 $381,000
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $129,076 - $143,319
-2,026 Reduced 19.33%
8,453 $540,000
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $53,882 - $61,114
820 Added 8.49%
10,479 $726,000
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $95,872 - $113,526
1,400 Added 16.95%
9,659 $694,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $387 - $228,983
2,980 Added 56.45%
8,259 $587,000
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $84,529 - $93,096
1,164 Added 28.29%
5,279 $406,000
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $252,990 - $303,357
4,115 New
4,115 $301,000
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $400,657 - $454,018
-6,939 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $95,735 - $106,087
1,667 Added 31.62%
6,939 $418,000
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $34,865 - $40,761
636 Added 13.72%
5,272 $310,000
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $215,110 - $312,605
4,636 New
4,636 $258,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track One Wealth Advisors, LLC Portfolio

Follow One Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on One Wealth Advisors, LLC with notifications on news.